IRADIMED Expects Q2 Revenues Of $17.6M-$17.8M Versus Consensus Of $17.88M
Portfolio Pulse from Benzinga Newsdesk
IRADIMED anticipates Q2 revenues to be between $17.6M and $17.8M, slightly below the consensus estimate of $17.88M.
May 02, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
IRADIMED's projected Q2 revenues are slightly below market expectations, indicating a potential short-term negative impact on its stock price.
Revenue forecasts that do not meet or exceed consensus estimates can lead to negative investor sentiment and a potential decrease in stock price. Given that IRADIMED's forecast is slightly below the consensus, this could lead to short-term bearish sentiment among investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100